CC

Commodore Capital Portfolio holdings

AUM $1.5B
1-Year Est. Return 149.78%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+149.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.05B
AUM Growth
+$632M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
40
New
Increased
Reduced
Closed

Top Buys

1
+$58.5M
2
+$54.9M
3
+$38.4M
4
TERN icon
Terns Pharmaceuticals
TERN
+$36.4M
5
LBRX
LB Pharmaceuticals
LBRX
+$23.8M

Top Sells

1
+$51.4M
2
+$37.6M
3
+$30.2M
4
VERA icon
Vera Therapeutics
VERA
+$18.8M
5
DFTX
Definium Therapeutics
DFTX
+$16.6M

Sector Composition

1 Healthcare 99.61%
2 Financials 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTMX icon
26
CytomX Therapeutics
CTMX
$825M
$24.5M 1.2%
7,692,300
LBRX
27
LB Pharmaceuticals
LBRX
$631M
$23.7M 1.16%
+1,500,000
TNGX icon
28
Tango Therapeutics
TNGX
$2.45B
$12.6M 0.62%
1,500,000
APGE icon
29
Apogee Therapeutics
APGE
$5.06B
$11.5M 0.56%
290,000
PEPG icon
30
PepGen
PEPG
$425M
$10.9M 0.53%
+2,357,319
ENTA icon
31
Enanta Pharmaceuticals
ENTA
$389M
$9.58M 0.47%
+800,000
SABS icon
32
SAB Biotherapeutics
SABS
$219M
$8.85M 0.43%
+4,401,500
IKT icon
33
Inhibikase Therapeutics
IKT
$241M
$8.74M 0.43%
5,397,488
PCSC
34
Perceptive Capital Solutions
PCSC
$124M
$7.92M 0.39%
750,000
AVTX icon
35
Avalo Therapeutics
AVTX
$309M
$6.14M 0.3%
483,000
VTGN icon
36
VistaGen Therapeutics
VTGN
$25M
$5.59M 0.27%
1,575,000
CBIO
37
Crescent Biopharma
CBIO
$352M
$5.36M 0.26%
450,829
-2,857
VERA icon
38
Vera Therapeutics
VERA
$2.94B
– –
-800,000
NGNE icon
39
Neurogene
NGNE
$345M
– –
-427,866
SRRK icon
40
Scholar Rock
SRRK
$4.8B
– –
-1,450,000
1
2